Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MFG
MFG logo

MFG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Mizuho Financial Group Inc (MFG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.290
1 Day change
4.47%
52 Week Range
10.280
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Mizuho Financial Group Inc (MFG) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the technical indicators show a neutral trend, and the options data suggests a lack of strong bullish sentiment, there are no significant positive catalysts or financial performance data to support a buy decision. The lack of recent congress trading data and the absence of Intellectia Proprietary Trading Signals further reduce the appeal of this stock for immediate investment.

Technical Analysis

The MACD histogram is positive at 0.0107 and expanding, indicating a slight bullish momentum. However, the RSI at 43.576 is neutral, and moving averages are converging, suggesting no strong trend. Key support and resistance levels are at S1: 7.588 and R1: 8, with the stock currently trading near the pivot level of 7.794.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • NULL identified.

Neutral/Negative Catalysts

  • No significant trading trends from hedge funds or insiders. Analyst downgrade from Goldman Sachs on a related financial stock, citing risks to margins and valuation concerns. No recent congress trading data available.

Financial Performance

No financial performance data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No specific analyst ratings or price target changes for MFG. However, a downgrade on a related financial stock by Goldman Sachs highlights risks to margins and valuation concerns in the sector.

Wall Street analysts forecast MFG stock price to rise
1 Analyst Rating
Wall Street analysts forecast MFG stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.940
sliders
Low
38.88
Averages
38.88
High
38.88
Current: 7.940
sliders
Low
38.88
Averages
38.88
High
38.88
Goldman Sachs
Neutral -> Sell
downgrade
$10 -> $9
AI Analysis
2026-01-08
Reason
Goldman Sachs
Price Target
$10 -> $9
AI Analysis
2026-01-08
downgrade
Neutral -> Sell
Reason
Goldman Sachs downgraded Magellan Financial to Sell from Neutral with a price target of A$9, down from A$10. The firm downgraded the shares relative to coverage reflecting ongoing downside risk to margins from mix impacts and ongoing weak performance outside Vinva, as well as valuation compared to peers. Capital management and associate performance present risks for the stock going into the result, the analyst tells investors in a research note.

People Also Watch